All the Active Ingredient Drugs
Hepatitis A Virus Antigen (Inactivated) 80 U / 0.5 ml. SUSP. FOR INJECT. (single dose prefilled
syringe): 1. Prim. vaccinat: 0.5 ml.
Booster within 6-8 mths. foll. initial dose.
I.M. in deltoid. See lit.
SUSP. FOR INJECT. (multidose vial): 10 x
0.5 ml. As above
Active immunizat. against hepatit. A
virus in child 12 mths-15 yrs (inclus.).
C/I: Hypersens. to active ingred.,
neomycin, polysorbate, foll. prev. inject.
Feber, acute/chron. evolv. dis. See lit.
Hepatitis A Vaccine. Hepatitis A Virus Antigen (Inactivated) 1440 E.L.U/ml. VIAL: 1×1ml. Primary
immunis. consists of a single dose
given IM. This provides anti-HAV
antibody. for at least one y. See lit.
Act. immunisation against infec. caused
by Hepatit. A virus.
The vaccine is particul. indic. for those
at incr. risk of infec. or transmis.
C/I: Hypersens.to the act. subst. or to
neomycin (present at traces).
Hepatitis A Vaccine. Hepatitis A Virus Antigen (Inactivated) 720 E.L.U / 0.5 ml. MONODOSE VIAL.: 1 x 0.5 ml/ vial.
Child./adolesc. (1-15 yrs.) Prim.
immunis. consists of a single dose
given IM. This provides anti-HAV
antibod. for at least 1 year. In order to
obtain more persist. immune., for at
least 10 yrs., a booster dose is recom.
btwn. 6- 12 mnths. after prim. immun.
See lit.
Active immune. against HAV infect. from
1 year up to and include.15 yrs. of age.
The vaccine is partic. indic.for those at
incr. risk of infect. or transmiss.
C/I: Hypersens.
Hepatitis Vaccines. Hepatitis A Virus Antigen (Inactivated) 25 U/0.5 ml, 50 U/ml. Adult formulat: 50 IU/1 ml; Ped./adolesc.
formulat: 25 IU/0.5 ml.
VIAL + SYRINGE: 1 + 1. 18 yrs and over:
Single 1.0 ml (~50U) dose at elected
date; booster dose 1.0 ml (~50U) 6
mths. later. Ped./Adolesc. 2-17 yrs:
Single 0.5 ml (~25U) dose at elected
date; booster dose 0.5 ml (~25U) 6-18
mths. later. See lit.
Active pre-exposure proph. hepatit. A in 2
yrs and older. Prim. immunizat. to be
given at least 2 wks. prior to expect.
exposure to HIV (see lit.).
C/I: Hypersens.
